Hyperactivated Wnt signaling induces synthetic lethal interaction with Rb inactivation by elevating TORC1 activities

Tianyi Zhang1, Yang Liao1, Fu-Ning Hsu2

  • 1Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.

Plos Genetics
|May 10, 2014
PubMed

Insights

Loss of the Rb tumor suppressor combined with Wnt pathway overactivation causes cell death. Inhibiting TORC1 activity or reducing metabolic stress can prevent this, suggesting new cancer therapy strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The retinoblastoma (Rb) tumor suppressor regulates cell proliferation; its inactivation can lead to cancer.
  • Understanding pathways interacting with Rb loss is crucial for cancer therapy development.
  • Wnt signaling is frequently deregulated in various cancers.

Purpose of the Study:

  • To identify novel synthetic lethal interactions with Rb inactivation.
  • To investigate the role of Wnt signaling in modulating the effects of Rb loss.
  • To explore therapeutic strategies targeting the synthetic lethality between Rb and Wnt signaling.

Main Methods:

  • Unbiased genetic screens in Drosophila to identify synthetic lethal interactions.
  • Analysis of metabolic gene expression and stress responses.
  • Investigation of the mechanistic link involving TORC1 signaling and apoptosis.
  • Conservation studies in mammalian cell lines.

Main Results:

  • A synthetic lethal interaction between Rb inactivation (rbf mutation) and deregulated Wg/Wnt signaling was identified.
  • Deregulated Wnt signaling induced metabolic alterations, hypersensitivity to fasting, and synergistic apoptosis with rbf mutation.
  • Hyperactivated Wnt signaling increased TORC1 activity, leading to energy stress and synergistic cell death with rbf.
  • Inhibition of TORC1 suppressed this synergistic cell death.
  • The synthetic lethality and underlying mechanism were conserved in mammalian cells with Rb and APC inactivation.

Conclusions:

  • Elevated TORC1 activity and metabolic stress are key components of the synthetic lethality between Wnt pathway hyperactivation and Rb inactivation.
  • This conserved interaction offers potential therapeutic targets for cancers with these genetic alterations.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

1.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K